New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America. The Clinics: Internal Medicine 26-3

  • ID: 4580108
  • Book
  • Region: America, North America, United States
  • 1440 Pages
  • Elsevier Health Science
1 of 3

Topics include: Targeting IGF-1R, Tyrosine Kinase Inhibitors in Lung Cancer, Targeting mTOR, Targeting Hedgehog, Mitotic Inhibitors, Topoisomerase I Inhibitors , and New Strategies and Drugs Inhibiting Folate Pathways.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown
2 of 3

Loading
LOADING...

3 of 3
Muggia, Franco
Note: Product cover images may vary from those shown
4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll